Impact of elevated antiapoptotic MCL1 and BCL2 on the development and treatment of MLLAF9 AML in mice

Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice

19:42 EST 23 Nov 2018 | Nature Publishing

More From BioPortfolio on "Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice"